Cargando…

MicroRNA-29a enhances cisplatin sensitivity in non-small cell lung cancer through the regulation of REV3L

Cisplatin-based chemotherapy may greatly enhance patient prognosis; however, chemotherapy resistance remains an obstacle to curing patients with non-small cell lung cancer (NSCLC). The aim of the present study was to explore the microRNAs (miRs) that could regulate cisplatin sensitivity and provide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Xialin, Zhu, Hong, Ye, Wanli, Cui, Yayun, Chen, Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323222/ https://www.ncbi.nlm.nih.gov/pubmed/30535450 http://dx.doi.org/10.3892/mmr.2018.9723

Ejemplares similares

MicroRNA-29a Functions as a Tumor Suppressor and Increases Cisplatin Sensitivity by Targeting NRAS in Lung Cancer
por: Liu, Xin, et al.
Publicado: (2018)

MicroRNAs as Predictors of Lung-Cancer Resistance and Sensitivity to Cisplatin
por: Konoshenko, Maria, et al.
Publicado: (2022)

MicroRNA-608 sensitizes non-small cell lung cancer cells to cisplatin by targeting TEAD2
por: Wang, Yanli, et al.
Publicado: (2019)

MicroRNAs as regulators of cisplatin-resistance in non-small cell lung carcinomas
por: Fadejeva, Irina, et al.
Publicado: (2017)

microRNA-660 Enhances Cisplatin Sensitivity via Decreasing SATB2 Expression in Lung Adenocarcinoma
por: Wang, Ziyao, et al.
Publicado: (2023)

Suppression of REV7 enhances cisplatin sensitivity in ovarian clear cell carcinoma cells
por: Niimi, Kaoru, et al.
Publicado: (2014)

Upregulation of microRNA-451 increases cisplatin sensitivity of non-small cell lung cancer cell line (A549)
por: Bian, Hai-Bo, et al.
Publicado: (2011)

MicroRNA-137 inhibits tumor growth and sensitizes chemosensitivity to paclitaxel and cisplatin in lung cancer
por: Shen, Hua, et al.
Publicado: (2016)

MicroRNA-340 inhibits the proliferation and promotes the apoptosis of colon cancer cells by modulating REV3L
por: Arivazhagan, Roshini, et al.
Publicado: (2017)

Long non-coding RNA TP73-AS1 accelerates the progression and cisplatin resistance of non-small cell lung cancer by upregulating the expression of TRIM29 via competitively targeting microRNA-34a-5p
por: Luo, Shunxiang, et al.
Publicado: (2020)

MicroRNA-595 sensitizes ovarian cancer cells to cisplatin by targeting ABCB1
por: Tian, Songyu, et al.
Publicado: (2016)

MicroRNA-182 modulates chemosensitivity of human non-small cell lung cancer to cisplatin by targeting PDCD4
por: Ning, Fang-ling, et al.
Publicado: (2014)

MicroRNA-21 Increases Proliferation and Cisplatin Sensitivity of Osteosarcoma-Derived Cells
por: Vanas, Vanita, et al.
Publicado: (2016)

MicroRNA-630 may confer favorable cisplatin-based chemotherapy and clinical outcomes in non-small cell lung cancer by targeting Bcl-2
por: Chen, Ming-Jenn, et al.
Publicado: (2018)

Quercetin Enhances Cisplatin Sensitivity of Human Osteosarcoma Cells by Modulating microRNA-217-KRAS Axis
por: Zhang, Xian, et al.
Publicado: (2015)

Therapeutic Delivery of MicroRNA-29b by Cationic Lipoplexes for Lung Cancer
por: Wu, Yun, et al.
Publicado: (2013)

MicroRNA 29a therapy for CEACAM6-expressing lung adenocarcinoma
por: Son, Seung-Myoung, et al.
Publicado: (2023)

MicroRNA-19b Promotes Nasopharyngeal Carcinoma More Sensitive to Cisplatin by Suppressing KRAS
por: Zhang, Yuan, et al.
Publicado: (2018)

MicroRNA-29a plays a suppressive role in non-small cell lung cancer cells via targeting LASP1
por: Hu, Zhaolan, et al.
Publicado: (2016)

MicroRNA-32 and MicroRNA-548a Promote the Drug Sensitivity of Non-Small Cell Lung Cancer Cells to Cisplatin by Targeting ROBO1 and Inhibiting the Activation of Wnt/β-Catenin Axis
por: Zheng, Jian, et al.
Publicado: (2021)

MicroRNA-29b Mediates Lung Mesenchymal-Epithelial Transition and Prevents Lung Fibrosis in the Silicosis Model
por: Sun, Jingping, et al.
Publicado: (2018)

MicroRNA-186 induces sensitivity of ovarian cancer cells to paclitaxel and cisplatin by targeting ABCB1
por: Sun, Kai-Xuan, et al.
Publicado: (2015)

MicroRNA-22 inhibits the proliferation and migration, and increases the cisplatin sensitivity, of osteosarcoma cells
por: Zhou, Xiang, et al.
Publicado: (2018)

Methylation-Mediated Silencing of MicroRNA-211 Decreases the Sensitivity of Melanoma Cells to Cisplatin
por: Li, Ning, et al.
Publicado: (2019)

MicroRNA‑224 promotes the sensitivity of osteosarcoma cells to cisplatin by targeting Rac1
por: Geng, Shuo, et al.
Publicado: (2016)

Pharmacogenomics of Cisplatin Sensitivity in Non-small Cell Lung Cancer
por: Rose, Maimon C., et al.
Publicado: (2014)

MicroRNA-29b attenuates non-small cell lung cancer metastasis by targeting matrix metalloproteinase 2 and PTEN
por: Wang, Hongyan, et al.
Publicado: (2015)

MicroRNA-7 sensitizes non-small cell lung cancer cells to paclitaxel
por: LIU, RONGHUA, et al.
Publicado: (2014)

MicroRNA 29 Family Serves a Key Role in Lung Development and the Prevention of Lung Pathology
por: Mishra, Ritu, et al.
Publicado: (2021)

Rev-erb in GABAergic Neurons Controls Diurnal Hepatic Insulin Sensitivity
por: Ding, Guolian, et al.
Publicado: (2021)

The microRNA-29 family in cartilage homeostasis and osteoarthritis
por: Le, Linh T. T., et al.
Publicado: (2015)

Exome sequencing reveals recurrent REV3L mutations in cisplatin-resistant squamous cell carcinoma of head and neck
por: Huang, Kie Kyon, et al.
Publicado: (2016)

CEACAM6 promotes cisplatin resistance in lung adenocarcinoma and is regulated by microRNA‐146a and microRNA‐26a
por: Du, He, et al.
Publicado: (2020)

Retracted: MicroRNA‐224 promotes the sensitivity of osteosarcoma cells to cisplatin by targeting Rac1
Publicado: (2019)

MicroRNA-765 sensitizes osteosarcoma cells to cisplatin via downregulating APE1 expression
por: Liang, Wei, et al.
Publicado: (2019)

Mad2B forms a complex with Cdc20, Cdc27, Rev3 and Rev1 in response to cisplatin-induced DNA damage
por: Kim, Ju Hwan, et al.
Publicado: (2023)

MicroRNA-29c functions as a tumor suppressor by targeting VEGFA in lung adenocarcinoma
por: Liu, Lipin, et al.
Publicado: (2017)

Demethoxycurcumin increases the sensitivity of cisplatin-resistant non-small lung cancer cells to cisplatin and induces apoptosis by activating the caspase signaling pathway
por: Chen, Yun, et al.
Publicado: (2020)

Implications of inhibition of Rev1 interaction with Y family DNA polymerases for cisplatin chemotherapy
por: Yoon, Jung-Hoon, et al.
Publicado: (2021)

Up-regulation of microRNA miR-101-3p enhances sensitivity to cisplatin via regulation of small interfering RNA (siRNA) Anti-human AGT4D and autophagy in non-small-cell lung carcinoma (NSCLC)
por: Cui, Dong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nacfnn07laqhcu5ail82a264op